Instil Bio earnings were -$47.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TIL earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$4.2M, down 48.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TIL reported annual earnings of -$71.4M, with -3.7% growth. The next TIL earnings date is Aug 12, 2026.
Instil Bio (NASDAQ: TIL) reported Q1 2026 earnings per share (EPS) of -$0.62, up 85.65% year over year. Total TIL earnings for the quarter were -$4.20 million. In the same quarter last year, Instil Bio's earnings per share (EPS) was -$4.32.
The next TIL earnings call is Aug 12, 2026. Add TIL to your watchlist to be reminded of Instil Bio's next earnings date.
Is Instil Bio profitable or losing money?
As of the last Instil Bio earnings report, Instil Bio is currently losing money. Instil Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$47.38 million, a 39.29% decrease year over year.
What was TIL's earnings growth in the past year?
As of Instil Bio's earnings date in Q3 2026, Instil Bio's earnings has grown year over year. TIL earnings in the past year totalled -$47.38 million.
What are Instil Bio's earnings expectations?
The current EPS estimate for Instil Bio's earnings report in Aug 12, 2026 is -$0.51.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.